Stepanova M - Search Results

1

Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States.

Stepanova M, Kanwal F, El-Serag HB, Younossi ZM. Stepanova M, et al. Hepatology. 2011 Mar;53(3):737-45. doi: 10.1002/hep.24131. Epub 2011 Feb 11. Hepatology. 2011. PMID: 21319199

2

Adipokines and cytokines in non-alcoholic fatty liver disease.

Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, Fang Y, Elariny H, Goodman Z, Chandhoke V, Younossi ZM. Jarrar MH, et al. Among authors: stepanova m. Aliment Pharmacol Ther. 2008 Mar 1;27(5):412-21. doi: 10.1111/j.1365-2036.2007.03586.x. Epub 2007 Dec 10. Aliment Pharmacol Ther. 2008. PMID: 18081738

3

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A. Younossi ZM, et al. Among authors: stepanova m. Obes Surg. 2008 Nov;18(11):1430-7. doi: 10.1007/s11695-008-9506-y. Epub 2008 May 24. Obes Surg. 2008. PMID: 18500507

4

Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin.

Younossi ZM, Baranova A, Afendy A, Collantes R, Stepanova M, Manyam G, Bakshi A, Sigua CL, Chan JP, Iverson AA, Santini CD, Chang SY. Younossi ZM, et al. Among authors: stepanova m. Hepatology. 2009 Mar;49(3):763-74. doi: 10.1002/hep.22729. Hepatology. 2009. PMID: 19140155

5

Predictors of health-related quality of life in patients with chronic liver disease.

Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, Marchesini G, Younossi ZM. Afendy A, et al. Among authors: stepanova m. Aliment Pharmacol Ther. 2009 Sep 1;30(5):469-76. doi: 10.1111/j.1365-2036.2009.04061.x. Epub 2009 Jun 9. Aliment Pharmacol Ther. 2009. PMID: 19508612

6

Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.

Younossi ZM, Afendy A, Stepanova M, Hossain N, Younossi I, Ankrah K, Gramlich T, Baranova A. Younossi ZM, et al. Among authors: stepanova m. Liver Int. 2009 Oct;29(9):1403-12. doi: 10.1111/j.1478-3231.2009.02060.x. Epub 2009 Jun 3. Liver Int. 2009. PMID: 19515216

7

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.

Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Rafiq N, Goodman Z, Younossi Z. Hossain N, et al. Among authors: stepanova m. Clin Gastroenterol Hepatol. 2009 Nov;7(11):1224-9, 1229.e1-2. doi: 10.1016/j.cgh.2009.06.007. Epub 2009 Jun 25. Clin Gastroenterol Hepatol. 2009. PMID: 19559819

8

Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C.

Birerdinc A, Afendy A, Stepanova M, Younossi I, Manyam G, Baranova A, Younossi ZM. Birerdinc A, et al. Among authors: stepanova m. J Viral Hepat. 2010 Oct;17(10):730-6. doi: 10.1111/j.1365-2893.2009.01235.x. J Viral Hepat. 2010. PMID: 20002302

9

Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease.

Stepanova M, Hossain N, Afendy A, Perry K, Goodman ZD, Baranova A, Younossi Z. Stepanova M, et al. Obes Surg. 2010 May;20(5):640-50. doi: 10.1007/s11695-010-0078-2. Epub 2010 Jan 30. Obes Surg. 2010. PMID: 20119733

10

Clinical predictors of fibrosis in patients with chronic liver disease.

Stepanova M, Aquino R, Alsheddi A, Gupta R, Fang Y, Younossi Z. Stepanova M, et al. Aliment Pharmacol Ther. 2010 May;31(10):1085-94. doi: 10.1111/j.1365-2036.2010.04266.x. Epub 2010 Feb 18. Aliment Pharmacol Ther. 2010. PMID: 20175770

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters